De novo MET amplification in EGFR-mutant non-small cell lung cancer

被引：0
|
作者：
Lee, D. D. W. [1 ]
Wang, L. [2 ]
Lai, G. [2 ]
Lim, T. K. H. [2 ]
Tan, D. S. W. [2 ]
机构：
[1] Univ Malaya, Dept Clin Oncol, Fac Med, Kuala Lumpur, Malaysia
[2] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
655P
引用
收藏
页码：S1649 / S1650
页数：3
相关论文
共 50 条
  • [41] The role of PD-L1 in EGFR-mutant non-small cell lung cancer
    Gao, Wentao
    Wang, Lingling
    Zhao, Yanyan
    Zhu, Lucheng
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [42] Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: End of the Road or the First Chapter?
    Ketpueak, Thanika
    Tan, Daniel S. W.
    Popat, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (34)
  • [43] Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
    Kim, Soomin
    Koh, Jaemoon
    Kim, Tae Min
    Oh, Songji
    Kim, Soyeon
    Youk, Jeonghwan
    Kim, Miso
    Keam, Bhumsuk
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Heo, Dae Seog
    ISCIENCE, 2025, 28 (02)
  • [44] A large real-world study on the effectiveness of the combined inhibition of EGFR and MET in EGFR-mutant advanced non-small cell lung cancer (NSCLC).
    Li, Liu
    Qu, Jingjing
    Heng, Jianfu
    Zhou, Chunhua
    Xiong, Yi
    Yang, Haiyan
    Jiang, Wenjuan
    Zeng, Liang
    Zhu, Songlin
    Zhang, Yongchang
    Tan, Jiarong
    Hou, Ting
    Lizaso, Analyn
    Chen, Zhiqiu
    Hu, Chengping
    Deng, Pengbo
    Yang, Nong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Cardiac Events and Survival in Patients With EGFR-Mutant Non-Small Cell Lung Cancer Treated With Osimertinib
    Lin, Chien-Yu
    Chang, Wei-Ting
    Su, Po-Lan
    Kuo, Chin-Wei
    Yang, Jen
    Lin, Chien-Chung
    Lin, Sheng-Hsiang
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [46] Spontaneously expectorated EGFR-mutant non-small-cell lung cancer
    Sumi, Toshiyuki
    Terai, Kotomi
    Chiba, Hirofumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (11) : 1094 - 1095
  • [47] Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis
    Benedettini, Elisa
    Sholl, Lynette M.
    Peyton, Michael
    Reilly, John
    Ware, Christopher
    Davis, Lenora
    Vena, Natalie
    Bailey, Dyane
    Yeap, Beow Y.
    Fiorentino, Michelangelo
    Ligon, Azra H.
    Pan, Bo-Sheng
    Richon, Victoria
    Minna, John D.
    Gazdar, Adi F.
    Draetta, Giulio
    Bosari, Silvano
    Chirieac, Lucian R.
    Lutterbach, Bart
    Loda, Massimo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (01): : 415 - 423
  • [48] A Rare Clinical Presentation Of EGFR-Mutant Non-Small Cell Lung Cancer With Oligo-Acrometastasis
    Kabalak, Pinar Akin
    Cengiz, Tuba Inal
    Yilmaz, Ugur
    Kizilgoz, Derya
    Karaca, Metehan
    Canbay, Fatma
    Uslu, Inci
    Agackiran, Yetkin
    Wang, Kyle
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S848 - S849
  • [49] Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer
    Masago, Katsuhiro
    Horio, Yoshitsugu
    Fujita, Shiro
    Yatabe, Yasushi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S391 - S394
  • [50] Treatment choice in EGFR-mutant non-small-cell lung cancer
    Brueckl, Wolfgang M.
    LANCET ONCOLOGY, 2017, 18 (11): : 1425 - 1426
12345